Augmented renal clearance in neurocritical patients: An epidemiological investigation and risk-factor analysis.
10.11817/j.issn.1672-7347.2024.240448
- Author:
Qile XIAO
1
;
Bohan LUO
2
;
Hainan ZHANG
3
;
Xiaomei WU
4
Author Information
1. Department of Neurology, Second Xiangya Hospital, Central South University, Changsha 410011, China. Xiaoqile@csu.edu.cn.
2. Department of Neurology, Second Xiangya Hospital, Central South University, Changsha 410011, China. luobohan@csu.edu.cn.
3. Department of Neurology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
4. Department of Neurology, Second Xiangya Hospital, Central South University, Changsha 410011, China. wuxiaomei0923@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
augmented renal clearance;
incidence;
neurocritical illness;
risk factors;
severe bacterial infections
- MeSH:
Humans;
Risk Factors;
Female;
Male;
Retrospective Studies;
Creatinine/blood*;
Middle Aged;
Intensive Care Units;
Aged;
Adult;
Incidence;
Critical Illness;
Renal Elimination;
Kidney/metabolism*
- From:
Journal of Central South University(Medical Sciences)
2024;49(11):1711-1721
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Augmented renal clearance (ARC), in contrast to renal dysfunction, refers to enhanced renal elimination of circulating solutes compared to the expected baseline. Although patients may present with normal serum creatinine (Scr) levels, the incidence of ARC is high in intensive care unit (ICU) settings. ARC is associated with subtherapeutic exposure and treatment failure of renally cleared antibiotics. However, limited research exists on the incidence and risk factors of ARC in the ICU, and even fewer data are available specifically for neurological ICU (NICU). This study aims to determine the incidence and risk factors of ARC in neurocritically ill patients.
METHODS:We retrospectively analyzed all available Scr data of neurocritical care patients admitted to the NICU of the Second Xiangya Hospital of Central South University between December 2020 and January 2023. Creatinine clearance (CrCl) was calculated using the Cockcroft-Gault equation. ARC was defined as a CrCl≥130 mL/(min·1.73 m2) sustained for more than 50% of the duration of the NICU stay. A total of 208 neurocritically ill patients were assigned into an ARC group (n=52) and a non-ARC (N-ARC) group (n=156). Clinical characteristics were compared between the 2 groups. Variables with P<0.05 in univariate analysis were included in binary Logistic regression to identify independent risk factors for ARC.
RESULTS:The incidence of ARC among neurocritically ill patients was 25.00%. Of the 74 patients with normal CrCl, 20 (27.03%) gradually developed ARC during hospitalization. Compared with the N-ARC group, the patients of the ARC group were younger (P<0.001), with a higher proportion of females (P=0.048) and a lower admission mean arterial pressure (MAP) (P=0.034). Moreover, patients of the ARC group were commonly complicated with severe bacterial infections compared with the patients of the N-ARC group (P<0.001). In binary Logistic regression analysis, younger age (OR=0.903, 95% CI 0.872 to 0.935) and severe bacterial infections (OR=6.270, 95% CI 2.568 to 15.310) were significant predictors of ARC.
CONCLUSIONS:ARC is relatively common in the NICU. A considerable number of patients with initially normal renal function developed ARC during hospitalization. Younger age and concurrent severe bacterial infection are important risk factors of ARC in neurocritically ill patients.
